Results 201 to 210 of about 172,791 (358)

A Nascent Nasal Phenomenon

JEADV Clinical Practice, EarlyView.
Amy Long, Claire Quigley, Lisa Murphy, Niamh Leonard, Julianne Clowry   +4 more
wiley   +1 more source

Optimising Vaccination Status in a Belgian Dermatological Immune‐Mediated Inflammatory Disease Population: An Education‐Based Pro‐Active Patient‐Centred Approach

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Patients with dermatological immune mediated inflammatory diseases (IMIDs) are increasingly treated with immunosuppressive and ‐modulating drugs. Some of these drugs increase the risk of acquiring infections and more complications can arise during an infection while treated with these agents.
Femke Lieten, Tine Vanhoutvin, Dorien Hunin, Céline Vanvelk, Liesbeth Gilissen, Petra De Haes, An Van Laethem, Francisca Castelijns, Tom Hillary   +8 more
wiley   +1 more source

Exploring the Impact of Gender and Age of Onset on Psoriasis Treatment Management. [PDF]

J Clin Med
Lax T, Stemmer E, Fallach N, Shrem G, Schreiber-Divon M, Ayalon S, Giat E, Mor I, Salmon-Divon M.   +8 more
europepmc   +1 more source

Patient and Clinician‐Reported Outcomes and Adherence to Calcipotriene/Betamethasone Dipropionate PAD‐Cream in Treatment of Scalp Psoriasis in Adults: An Interim Analysis of the PRO‐SCALP Study

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Effective management of scalp psoriasis needs treatment with high patient preference and treatment satisfaction. Clinical trials show promising results for calcipotriene and betamethasone dipropionate cream based on polyaphron dispersion (PAD) technology (CAL/BDP PAD‐cream). However, real‐world data are scarce.
Andreas Pinter, Jose Luis López Estebaranz, Anthony Bewley, Jordi Galván, Siva Narayanan, Volker Koscielny, Ismail Kasujee   +6 more
wiley   +1 more source

Ambient Solar Radiation Predicts Psoriasis Treatment Intensity. [PDF]

Photodermatol Photoimmunol Photomed
Woodie BR, Fleischer AB.
europepmc   +1 more source

[Recommendations for psoriasis treatment in Pediatrics]. [PDF]

Rev Fac Cien Med Univ Nac Cordoba, 2023
Luna PC, Abad ME, Larralde M, Boggio P, Ferrari B, Maccario MF, Castro C, Moreno S, Kaplan D, Echeverría C.   +9 more
europepmc   +1 more source

Mycosis Fungoides in Paediatric Patients: A Real‐Life Retrospective Study

JEADV Clinical Practice, EarlyView.
Our study represents the largest cohort of children with MF worldwide, providing relevant evidence supporting phototherapy as first‐line treatment, with an overall remission rate of 36.36%. Both topical and systemic therapy also showed favourable outcomes.
Mariana de la Vega, María Antonieta Domínguez Gómez, Martha Alejandra Morales‐Sánchez   +2 more
wiley   +1 more source

Interventions in cytokine signaling: novel horizons for psoriasis treatment. [PDF]

Front Immunol
Li L, Liu J, Lu J, Wu J, Zhang X, Ma T, Wu X, Zhu Q, Chen Z, Tai Z.   +9 more
europepmc   +1 more source

Weighted Gene Co-Expression Network Analysis of Oxymatrine in Psoriasis Treatment. [PDF]

J Inflamm Res, 2023
Xue X, Guo Y, Zhao Q, Li Y, Rao M, Qi W, Shi H.   +6 more
europepmc   +1 more source

Role of the Microcirculation in the Treatment and Pathogenesis of Psoriasis

, 1982
Irwin M. Braverman, Jane Sibley
openalex   +1 more source